A Trial Comparing Transversus Abdominis Plane Catheter Versus Epidural After Esophagectomy

Sponsor
Swedish Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT03570996
Collaborator
(none)
90
1
2
41
2.2

Study Details

Study Description

Brief Summary

A randomized trial comparing perioperative outcomes between bilateral transversus abdominis plane TAP catheters with patient controlled analgesia (PCA) to epidural for esophagectomy patients with a VATS chest approach. Further objectives are to determine pain requirements between multiple modalities of pain control and compare the subsequent sequelae of narcotic use and blood pressure control and to compare complications such as anastomotic leak, atrial fibrillation and perioperative morbidity and mortality between the two groups.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Esophagectomy
  • Procedure: Transversus abdominis plane catheter
  • Procedure: Epidural
N/A

Detailed Description

Epidural analgesia is considered the 'gold standard' for post-operative analgesia following open esophagectomy. Epidurals have been shown to reduce post-operative pulmonary morbidity and mortality. However, epidurals are often associated with sympathetic blockade that creates hypotension and could therefore adversely affect the conduit. Pain management techniques that use peripheral nerve blockade are becoming more prevalent, reducing the need for an epidural. Transversus abdominis plane (TAP) catheters have been used in colorectal and abdominal surgery showing equivocal pain scores to epidurals. With the minimally invasive chest approach, the analgesia coverage focuses on the abdominal incision where both epidurals and TAPs are considered standard of care.

The investigators have completed a retrospective study in preparation for a randomized control trial. The investigators previous retrospective study found that TAP blocks/catheters are a reasonable alternative to epidurals, providing adequate pain coverage for abdominal incisions. The study found no statistical difference in pain scores between the two groups. The TAP group had a lower prevalence of hypotension and lower crystalloid resuscitation needs. Pulmonary complications were similar between the two groups. This retrospective review showed that TAP blocks are a reasonable alternative to epidurals and may reduce episodes of hypotension. The investigators aim is to now expand this study to a randomized control trial.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
Randomization into either transversus abdominis plane catheter (TAP) or epidural for patients undergoing esophagectomyRandomization into either transversus abdominis plane catheter (TAP) or epidural for patients undergoing esophagectomy
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Randomized Controlled Trial Comparing Transversus Abdominis Plane Catheter Versus Epidural After Esophagectomy
Actual Study Start Date :
Jan 1, 2018
Anticipated Primary Completion Date :
Jan 1, 2021
Anticipated Study Completion Date :
Jun 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Transversus abdominis plane catheter

Transversus abdominis plane catheter (TAP) for pain control in esophagectomy operations. TAP group will have bilateral subcostal TAP catheters and single shot bilateral rectus sheath blocks placed at the end of the surgery, prior to emergence. Bilateral subcostal TAP catheters will be bolused with 20ml of .2% ropivacaine on each side and then infused with .2% ropivacaine at 10ml/ hr for 75 hours each. Rectus sheath blocks will be bilateral bolus 20ml of .2% ropivacaine.

Procedure: Esophagectomy
Esophagectomy with minimally invasive approach of the chest including: 3 hole with R video-assisted thoracoscopic surgery (VATS), Ivor Lewis R VATS, Transhiatal

Procedure: Transversus abdominis plane catheter
TAP group will have bilateral subcostal TAP catheters and single shot bilateral rectus sheath blocks placed at the end of the surgery, prior to emergence. Bilateral subcostal TAP catheters will be bolused with 20ml of .2% ropivacaine on each side and then infused with .2% ropivacaine at 10ml/ hr for 75 hours each. Rectus sheath blocks will be bilateral bolus 20ml of .2% ropivacaine
Other Names:
  • TAP catheter
  • Active Comparator: epidural

    Epidural pain control for pain control in esophagectomy operation. Patients randomize the TEP group will have bilateral TEP placed at T8-9 +/- one level based on patient anatomy. TEP will be bolused with 5ml of 1.5% lidocaine with epinephrine and then started on infusion of .0625% bupivacaine plus 4 mcg/ml fentanyl plus 2 mcg/ ml epinephrine at 6ml/hr with a range of 6-12 ml/hr, titrating to optimize patient comfort. Epidurals are placed before surgery start time.

    Procedure: Esophagectomy
    Esophagectomy with minimally invasive approach of the chest including: 3 hole with R video-assisted thoracoscopic surgery (VATS), Ivor Lewis R VATS, Transhiatal

    Procedure: Epidural
    Patients randomize the TEP group will have bilateral TEP placed at T8-9 +/- one level based on patient anatomy. TEP will be bolused with 5ml of 1.5% lidocaine with epinephrine and then started on infusion of .0625% bupivacaine plus 4 mcg/ml fentanyl plus 2 mcg/ ml epinephrine at 6ml/hr with a range of 6-12 ml/hr, titrating to optimize patient comfort. Epidurals are placed before surgery start time.
    Other Names:
  • TEP
  • Outcome Measures

    Primary Outcome Measures

    1. Pain scores [Up to post-operative day 4]

      Pain scores on a scale of 0-10 will be collected from patients twice a day

    Secondary Outcome Measures

    1. Volume Resuscitation [Up to post-operative day 4]

      Amount of fluids given to patient

    2. Hypotension [Up to post-operative day 4]

      Total episodes of hypotension

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All adult individuals who undergo an esophagectomy with a minimally invasive approach of the chest at Swedish Medical Center-First Hill. These approaches include:

    • 3 hole with R video-assisted thoracoscopic surgery (VATS)

    • Ivor Lewis R VATS

    • Transhiatal

    Exclusion Criteria:
    • Age <18

    • Unable to consent

    • Additional surgical procedures planned

    • Patient with chronic pain on a daily regimen of narcotics

    • Patients who remain intubated greater than 24 hours post operatively

    • Non-English speaking

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Swedish Cancer Institute Seattle Washington United States 98104

    Sponsors and Collaborators

    • Swedish Medical Center

    Investigators

    • Principal Investigator: Brian E Louie, MD, Swedish Cancer Institute and Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Swedish Medical Center
    ClinicalTrials.gov Identifier:
    NCT03570996
    Other Study ID Numbers:
    • STUDY2017000592
    First Posted:
    Jun 27, 2018
    Last Update Posted:
    Dec 19, 2018
    Last Verified:
    Dec 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Swedish Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 19, 2018